Prof. Arthur E. Frankel
Scientific Advisor
Scientific Advisory Board
Erytech
France
Biography
Prof. Arthur E. Frankel, M.D., Ph.D. serves as Consultant of Erytech Pharma Société Anonyme. Prof. Frankel is Professor of internal medicine, division of Hematology and Oncology at the University of Texas Southwestern Medical Center. Prof. Frankel serves as Head of the Division of Hematology/Oncology at the Scott & White Cancer Institute Texas, United States and Professor at the Texas Health Science Center College of Medicine. He is leader of Phase 1 clinical trials, Harold Simmons Comprehensive Cancer Center. Prof. Frankel worked on the deprivation of amino acid as a cancer therapy. He has been Member of Scientific Advisory Board at Aeglea Biotherapeutics, Inc. since September 2016. Prof. Frankel has been a Member of Scientific Board at Erytech Pharma Société Anonyme since 2012.
Research Interest
Moloecular designing on Oncoloy